Event Schedule

Third Regional Pneumococcal Symposium - Schedule and materials

Day 1 - Wednesday, 13 February, 2008

7:30 - 8:00 | Breakfast/Registration

8:00 - 8:30 | Welcome Remarks

8:30 - 9:00 | Keynote Address - Najwa Khuri-Bulos

Session I: Global Pneumococcal Epidemiology

Chairperson: Ciro de Quadros

9:00 - 9:20 | Global Pneumococcal Disease Burden- Thomas Cherian

9:20 - 9:40 | Global Pneumococcal Serotype Project - Hope Johnson

9:40 - 10:00 | Break

Session II: Pneumococcal Epidemiology in the Region

Chairperson: Ghassan Dbaibo

10:00 - 10:20 | Issues in Pneumococcal Disease Surveillance - Orin Levine

10:20 - 10:35 | Diagnosis of Pneumococcal Disease: Limitations of surveillance for invasive disease - David Murdoch

10:35 - 10:50 | Long-term sequelae associated with pneumococcal disease - Samir Saha

10:50 - 11:05 | Burden of pneumococcal disease in region - Mehmet Ceyhan

11:05 - 11:20 | Antibiotic Resistance in the region - Cigdem Kayacan

11:20 - 12:00 | Discussion

12:00 - 13:00 | Lunch

Session III: Impact of Conjugate Pneumococcal Vaccines: Direct and Indirect Effects

Chairperson: Thomas Cherian

13:00 - 13:15 | Vaccine Efficacy: IPD and Pneumonia - Hanna Nohynek

13:15 - 13:30 | Pneumococcal Vaccine Efficacy against Otitis Media - Terhi Kilpi

13:30 -13:45 | Vaccine Effectiveness: Post Licensure Experience in the USA - Rosalyn O'Loughlin

13:45 - 14:15 | Discussion

Session IV: Issues in Conjugate Vaccination and Vaccine Development Update

Chairperson: Zulfiqar Bhutta

14:15 - 14:30 | Serotype Replacement in Perspective - Ron Dagan

14:30 - 14:45 | Wyeth Existing and Upcoming Vaccines - Peter Paradiso

14:45 - 15:00 | Break

15:00 - 15:15 | GSK Vaccine Development - Bernard Hoet

15:15 - 15:30 | PATH vaccine development - Mark Alderson

15:30 - 15:45 | Emerging Market Vaccine Manufacturers - Akira Homma

15:45 - 16:15 | Discussion

16:15 - 16:45 | First Day Closing Remarks

Day 2 - Thursday, 14 February, 2008

Session V: Country Spotlights

Chairperson: Najwa Khuri-Bulos

9:00 - 9:15 | Turkey - Mehmet Ceyhan

9:15 - 9:30 | Lebanon - Ghassan Dbaibo

9:30 - 9:45 | Saudi Arabia - Ziad Memish

9:45 - 10:00 | Israel - David Greenberg

10:00 - 10:20 | Break

10:20 - 10:35 | Tunisia - Amel Kechrid

10:35 - 10:50 | Morocco - Naima Elmdaghri

10:50 - 11:10 | Discussion

Session VI: Vaccine Advocacy, Economic and Implementation Issues

Chairperson: Ron Dagan

11:10 - 11:30 | Cost-Effectiveness of the Pneumococcal Conjugate Vaccine and the impact of the Indirect Effect: A Review - Tom Ray

Round Table Discussions

11:30- 12:20 | Implementation Issues - Santiago Cornejo (Consultant), Rosalyn O'Loughlin (Hib Initiative), Liudmila Mosina (WHO)

12:20 - 12:40 | Discussion

12:40 - 14:00 | Lunch

14:00 - 14:30 | News from the GAVI Alliance - Tania Cernuschi

14:30 - 15:15 | PACE - Awareness Building for Pneumococcal Disease - Ciro de Quadros, Lulu Bravo, Zulfiqar Bhutta

15:15 - 15:30 | Break

15:30 - 16:15 | Panel: The Need for Accelerated Conjugate Pneumococcal Vaccination: A Call to Action in the region - Ener Cagri Dinleyici, Ciro de Quadros, Orin Levine

16:15 - 16:45 | Discussion

16:45 - 17:00 | Closing Remarks - Zulfiqar Bhutta